Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M505804200 on October 3, 2005

J. Biol. Chem., Vol. 280, Issue 51, 42290-42299, December 23, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/51/42290    most recent
M505804200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shamloo, M.
Right arrow Articles by Oksenberg, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shamloo, M.
Right arrow Articles by Oksenberg, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Death-associated Protein Kinase Is Activated by Dephosphorylation in Response to Cerebral Ischemia*

Mehrdad Shamloo{ddagger}1, Liza Soriano{ddagger}, Tadeusz Wieloch§, Karoly Nikolich{ddagger}, Roman Urfer{ddagger}, and Donna Oksenberg{ddagger}

From the {ddagger}AGY Therapeutics, Inc., South San Francisco, California 94080 and §Laboratory for Experimental Brain Research, Wallenberg Neuroscience Center, Lund University, BMCA13, 22184 Lund, Sweden

Death-associated protein kinase (DAPK) is a calcium calmodulin-regulated serine/threonine protein kinase involved in ischemic neuronal death. In situ hybridization experiments show that DAPK mRNA expression is up-regulated in brain following a global ischemic insult and down-regulated in ischemic tissues after focal ischemia. DAPK is inactive in normal brain tissues, where it is found in its phosphorylated state and becomes rapidly and persistently dephosphorylated and activated in response to ischemia in vivo. A similar dephosphorylation pattern is detected in primary cortical neurons subjected to oxygen glucose deprivation or N-methyl-D-aspartate (NMDA)-induced toxicity. Both a calcineurin inhibitor, FK506, and a selective NMDA receptor antagonist, MK-801, inhibit the dephosphorylation of DAPK after in vitro ischemia. This indicates that DAPK could be activated by NMDA receptor-mediated calcium flux, activation of calcineurin, and subsequent DAPK dephosphorylation. Moreover, concomitantly to dephosphorylation, DAPK is proteolytically processed by cathepsin after ischemia. Furthermore, a selective DAPK inhibitor is neuroprotective in both in vitro and in vivo ischemic models. These results indicate that DAPK plays a key role in mediating ischemic neuronal injury.


Received for publication, May 27, 2005 , and in revised form, September 14, 2005.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: AGY Therapeutics, Inc. 270 E. Grand Ave., South San Francisco, CA 94080. Tel.: 650-228-1151; Fax: 650-615-4544; E-mail: mshamloo{at}agyinc.com.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Neurosci.Home page
F. X. Soriano, M.-A. Martel, S. Papadia, A. Vaslin, P. Baxter, C. Rickman, J. Forder, M. Tymianski, R. Duncan, M. Aarts, et al.
Specific Targeting of Pro-Death NMDA Receptor Signals with Differing Reliance on the NR2B PDZ Ligand
J. Neurosci., October 15, 2008; 28(42): 10696 - 10710.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Arab, K. Kuemmerer, J. Wang, C. Bode, and C. Hehrlein
Oxygenated Perfluorochemicals Improve Cell Survival during Reoxygenation by Pacifying Mitochondrial Activity
J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 417 - 424.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y.-T. Chuang, L.-W. Fang, M.-H. Lin-Feng, R.-H. Chen, and M.-Z. Lai
The Tumor Suppressor Death-Associated Protein Kinase Targets to TCR-Stimulated NF-{kappa}B Activation
J. Immunol., March 1, 2008; 180(5): 3238 - 3249.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Lin, C. Stevens, and T. Hupp
Identification of a Dominant Negative Functional Domain on DAPK-1 That Degrades DAPK-1 Protein and Stimulates TNFR-1-mediated Apoptosis
J. Biol. Chem., June 8, 2007; 282(23): 16792 - 16802.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
X.-M. Li, J.-M. Yang, D.-H. Hu, F.-Q. Hou, M. Zhao, X.-H. Zhu, Y. Wang, J.-G. Li, P. Hu, L. Chen, et al.
Contribution of Downregulation of L-type Calcium Currents to Delayed Neuronal Death in Rat Hippocampus after Global Cerebral Ischemia and Reperfusion
J. Neurosci., May 9, 2007; 27(19): 5249 - 5259.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Jin, E. K. Blue, and P. J. Gallagher
Control of Death-associated Protein Kinase (DAPK) Activity by Phosphorylation and Proteasomal Degradation
J. Biol. Chem., December 22, 2006; 281(51): 39033 - 39040.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement